Skip to content

PHARMABAK

Active Private limited company (pre-2019)founded 2015active for 11 yearsFerdinand Elbersstraat 5, 1080 Molenbeek-Saint-JeanKBO/BCE: BE 0578.906.094

Lifetime

11 annual accounts with figures on one time axis
peak of €125,035 in 2021
-€10,053▼ €26,140
lowest -€29,717 in 2025
-€29,717▼ €33,799
peak of €125,378 in 2018
€51,008▼ 36.8%
€306,507▼ 10.5%
peak of 1.2 FTE in 2016
-not published
Board2 names since 2015
1 director
Documentsfilings and deeds
23-06-202638 days before the deadline
2025micro format
Gross margin from €16,087 to -€10,053Loss of €29,717Equity from €80,725 to €51,008Cash from €13,487 to €24,837

Key points

from the 2025 annual accounts

Equity

€51,008 from €125,378 in 2018

Equity fell by 59% in 7 years.

Debts

€306,507 86% of the balance sheet

Position in the sector

-€29,717

Lower net result than 92% of companies in retail trade. Sector median €4,757 · 25,309 companies.

Turnover not published in the micro format

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 2,168 companies had the same profile as PHARMABAK has now. Each dot stands for 6 companies, two years later.

94.0%
were still trading
3.1%
stopped another way
2.5%
went bankrupt
  • Micro
  • 10 to 20 years old
  • solvency 10 to 30%
  • a small loss

Another 0.3% stopped without a precise date, possibly only after those two years.

Test of the method

The method was tested on the 497,962 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 0.9%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 2.9% 3.1%
10 5.6% 6.1%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 2,168 companies, not a prediction for PHARMABAK. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Manager
  • founderdeed of 28-01-2015
  • founderdeed of 28-01-2015
Board & ownership

Recent changes

resigns as director Director discharge: (director (not named in the articles)) · General meeting of 26-11-2025 · Gazette deed
Registered in the Peppol Directory Reachable for e-invoices through 0208:0578906094
appointed as manager General meeting of 10-01-2017 · Gazette deed
Registered office moved from Schaerbeek to Molenbeek-Saint-Jean The registered office moved from Avenue Louis Bertrand 20, 1030 Schaerbeek to Rue Ferdinand Elbers 5-1 1080 Molenbeek-Saint-Jean · Board meeting of 26-05-2017 · Gazette deed
All 23 events

Comparable companies

same main activity, similar in size and age
Company
PHARMABAK Molenbeek-Saint-Jean €357,515 -€10,053 14.3% -
CODEMA PHARMA Brussels €375,959 -€34,489 19.0% -
AKSA PHARMA Brussels €293,776 -€84,856 -21.8% 1.6
APOTHECA Saint-Josse-ten-Noode €286,294 -€547 63.0% -
NATHYPHARM Andenne €340,634 -€4,355 19.2% -
THEUNISSEN-DE NEVE Aalst €291,003 -€539 13.6% -
Apotheek Ruben Jolie Erpe-Mere €363,985 -€8,360 2.7% -

These companies have the same main activity as PHARMABAK: retail sale of pharmaceutical products (NACE 47730). They are comparable in size and age: total assets between €286,000 and €376,000, founded between 2008 and 2017.

Official details

Source: KBO
Status
Active since 26-01-2015Normal situation
Activity
Retail sale of pharmaceutical productsNACE 47730
Joint committee
313Pharmacies and pricing offices · annual accounts 2021
Establishment unit
2.303.773.1601080 Molenbeek-Saint-Jean, registered on 26-01-2015
Financial year end
31 December
Peppol
Reachable since 26-11-2025
Company details

Annual accounts 2025

€357,515▼ 15.5%
≈ 0 FTEestimated
Filing
Filed on 23-06-2026, 38 days before the end of the filing period
Financials

Insights on PHARMABAK

PHARMABAK files the micro format. That format states no turnover. The gross margin fell from €31,959 in 2015 to -€10,053 in 2025.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about PHARMABAK

What is the company number of PHARMABAK?
The company number of PHARMABAK is 0578.906.094. The VAT number is the same number with BE in front: BE 0578.906.094.
Where is PHARMABAK based?
The registered office is at Ferdinand Elbersstraat 5, 1080 Molenbeek-Saint-Jean.Company details
What does PHARMABAK do?
According to the KBO register, the main activity is retail sale of pharmaceutical products (NACE 47730).
What is the legal form of PHARMABAK?
PHARMABAK is a private limited company (pre-2019) (BVBA).
When was PHARMABAK founded?
PHARMABAK was founded on 26-01-2015.
Is PHARMABAK still active?
Yes, PHARMABAK is an active enterprise in the KBO register.
How many employees does PHARMABAK have?
PHARMABAK had an average of 0.9 full-time equivalents in financial year 2021, according to the filed annual accounts.Financials
Which joint committee does PHARMABAK fall under?
In its 2021 annual accounts, PHARMABAK states joint committee 313 (Pharmacies and pricing offices).
What is the turnover of PHARMABAK?
The annual accounts for financial year 2025 state no turnover. The micro format does not require it.
Is PHARMABAK profitable?
In financial year 2025, PHARMABAK made a loss of €29,717.
Where can I find the annual accounts of PHARMABAK?
PHARMABAK filed 11 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of PHARMABAK due?
PHARMABAK must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.